
Charles Cowey
Physician · Texas Oncology
Credentials: · · · ·
History
Research
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine · 2015 · 6,426 citations
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2019 · 2,973 citations
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2017 · 2,952 citations
- RG
10 papers
- CL
9 papers

9 papers

8 papers

8 papers · 1 as a fellow
- LF
8 papers
- JW
7 papers
- NK
7 papers
Clinical trials
- 2026–2028
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Aminex Therapeutics, Inc.
- 2024–2031
Site PI · Recruiting · Phase 3
Replimune, Inc.




